午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
$400 million of money laundering by drug companies; Forty percent of the cash for the drug was given to hospitals and doctors
 
Author:中國銘鉉 企劃部  Release Time:2017-6-15 15:22:47  Number Browse:606
 
The medical net on June 15 the news of the big case again! $400 million of money laundering by drug companies; The drug is in cash, and 40% is for the hospital and the doctor! 
 
▍ drug firms open shell company money laundering, involved 400 million 
 
On June 14, the state administration of taxation and the ministry of public security jointly oversaw the development of a VAT invoice in the pharmaceutical industry, CCTV reported on June 14. In the absence of a deal, the suspects used a large number of value-added tax invoices, worth more than $400 million, using a large amount of value-added tax invoices from more than 20 companies. 
 
The main character in the case is guangzhou jinlai pharmaceuticals. 
 
The pharmaceutical company and its shareholders open shell companies, make false trade records, and inflate the VAT invoice for themselves. 
 
After check, the two door open to guangdong this invoice of enterprise, after multiple backflow of funds, directly back to guangdong today or control personnel's personal bank account, form a complete money back home. 
 
▍ wash out money, flow to the drug, doctors, bidding and purchasing... 
 
Inspectors in the confiscation of corporate financial records, found more than the record in sales account is not consistent with the company funds, transaction object is mainly downstream terminal, such as hospitals, pharmacy, etc. 
 
After the interrogation, the suspect confessed the usage of funding for the illicit gains of falsely making out invoice, including through a medical representative to a lot of link such as drug procurement bidding platform, the indemnification. From medicine and medical devices to wholesale and retail, medical representatives, doctors to pharmacies, hospitals, and strict division of labor, constitute a full interest chain. 
 
In fact, the heart of the case, and the starting point for some of the suspects' operations, is still being sold in gold. Kickbacks to doctors, through joint cost can't find the real income to buy tickets, in addition, due to the amount of these fees is too big, lead to enterprise desperate, who tested. 
 
▍ hospital, the doctor took 40% 
 
In the CCTV report, inspectors of capital flows, in this case, a medical representative by taking cash and "ticket" and other forms to the cost of the medical institutions and doctors as high as 40%. 
 
The cost of transfers to hospitals and doctors is 40 per cent of the $400 million, which is not covered in the report. If so, it will not be a small number. Inspectors also found that 70-90% of the retail price of the drug went to intermediate and hospital terminals. 
 
▍ shot, hit the industry contact interests chain 
 
The government has stepped in to crack down on hidden interest chains in the industry. It is one of the measures to crack down on the use of VAT invoices by pharmaceutical companies. 
 
At the same time, the national health and family planning commission (NHFPC) has also maintained high pressure. On June 12, the national health and family planning commission held a press conference on strengthening health planning system. The health and family planning commission said that there was zero tolerance for the problem of the practice and maintained a high pressure. 
 
To find out the real problem, punch, cutting, do each question individually regulation, go through the motions, make form, zero tolerance, merciless, enhancing the high tension line industry. 
 
We believe that there will be positive improvement in the bad climate in the industry. 
 
Previous article:Ministry of commerce: national medicine batch, pharmacy 100 strong list, have you many customers!
Next article:The decline of hydroxymorphine, the abuse of the analgesic drug market?
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號